Education
About Us
Working with TipRanks
Follow Us
MBX Biosciences, Inc. (MBX)
NASDAQ:MBX
| Dec 24 | Dec 23 | Dec 22 | |
|---|---|---|---|
| Income Statement | |||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 |
| Operating Income | $ -68.19M | $ -35.31M | $ -25.16M |
| EBITDA | $ -67.95M | $ -35.15M | $ -25.70M |
| Net Income | $ -61.92M | $ -32.56M | $ -26.14M |
| Balance Sheet | |||
| Cash & Short-Term Investments | $ 262.15M | $ 80.68M | $ 42.46M |
| Total Assets | $ 268.54M | $ 84.18M | $ 45.09M |
| Total Debt | $ 171.00K | $ 324.00K | $ 461.00K |
| Net Debt | $ -49.18M | $ -30.20M | $ -23.75M |
| Total Liabilities | $ 11.09M | $ 156.65M | $ 87.70M |
| Stockholders' Equity | $ 257.44M | $ -72.47M | $ -42.60M |
| Cash Flow | |||
| Free Cash Flow | $ -55.55M | $ -32.11M | $ -23.56M |
| Operating Cash Flow | $ -54.68M | $ -31.98M | $ -23.12M |
| Investing Cash Flow | $ -160.59M | $ -30.93M | $ -11.41M |
| Financing Cash Flow | $ 234.10M | $ 69.22M | $ 46.06M |